AcelRx Pharmaceuticals Inc (ACRX) stock has fallen -18.96% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ACRX stock a score of 82 out of a possible 100.
That rank is mainly influenced by a fundamental score of 87. In addition to the average rating from Wall Street analysts, ACRX stock has a mean target price of 6. This means analysts expect the stock to increase 250.88% over the next 12 months. ACRX's rank also includes a long-term technical score of 85. The short-term technical score for ACRX is 75.
What's Happening with ACRX Stock Today
AcelRx Pharmaceuticals Inc (ACRX) stock has risen 7.3% while the S&P 500 is up 0.59% as of 11:33 AM on Friday, Oct 9. ACRX is up $0.12 from the previous closing price of $1.59 on volume of 1,539,408 shares. Over the past year the S&P 500 has gained 18.01% while ACRX has fallen -18.96%. ACRX lost -$0.62 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on AcelRx Pharmaceuticals Inc (ACRX) Stock.
